Characteristics of β-oxidative and reductive metabolism on the acyl side chain of cinnamic acid and its analogues in rats

[1]  K. Onoda,et al.  Retrospective Analysis of Argatroban in 353 Patients with Acute Noncardioembolic Stroke. , 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[2]  Chengxiao Fu,et al.  Simultaneous determination of Pyragrel, a novel anti‐thrombotic agent, and its two primary metabolites in plasma by HPLC–MS/MS , 2018, Journal of pharmaceutical and biomedical analysis.

[3]  Jie Huang,et al.  Profiling and Preparation of Metabolites from Pyragrel in Human Urine by Online Solid-Phase Extraction Coupled with High Performance Liquid Chromatography Tandem Mass Spectrometry Followed by a Macroporous Resin-Based Purification Approach , 2017, Molecules.

[4]  J. Papadopoulos,et al.  Allergic Reactions in Hospitalized Patients With a Self-Reported Penicillin Allergy Who Receive a Cephalosporin or Meropenem , 2017, Journal of pharmacy practice.

[5]  Yue Liu,et al.  Docking and molecular dynamics studies on triclosan derivatives binding to FabI , 2017, Journal of Molecular Modeling.

[6]  Jinzi Wu,et al.  Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications , 2016, Diabetes, metabolic syndrome and obesity : targets and therapy.

[7]  L. Wojtczak,et al.  Short- and medium-chain fatty acids in energy metabolism: the cellular perspective , 2016, Journal of Lipid Research.

[8]  A. Verrotti,et al.  Valproic acid and nonalcoholic fatty liver disease: A possible association? , 2015, World journal of hepatology.

[9]  F. Quiocho,et al.  Crystal Structure of the Human Fatty Acid Synthase Enoyl-Acyl Carrier Protein-Reductase Domain Complexed with Triclosan Reveals Allosteric Protein-Protein Interface Inhibition* , 2014, The Journal of Biological Chemistry.

[10]  Xiao-dong Liu,et al.  Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes , 2014, Acta Pharmacologica Sinica.

[11]  Xiao-dong Liu,et al.  Co-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure , 2014, Acta Pharmacologica Sinica.

[12]  X. Chen,et al.  MC-002 exhibits positive effects against platelets aggregation and endothelial dysfunction through thromboxane A2 inhibition. , 2014, Thrombosis research.

[13]  Masahiro Ito,et al.  Identification of fused-ring alkanoic acids with improved pharmacokinetic profiles that act as G protein-coupled receptor 40/free fatty acid receptor 1 agonists. , 2012, Journal of medicinal chemistry.

[14]  J. Saurat,et al.  A toxicologic and dermatologic assessment of cinnamyl phenylpropyl materials when used as fragrance ingredients. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[15]  Guangji Wang,et al.  Opposite Effect of Diabetes Mellitus Induced by Streptozotocin on Oral and Intravenous Pharmacokinetics of Verapamil in Rats , 2011, Drug Metabolism and Disposition.

[16]  Toshimasa Tanaka,et al.  Design, synthesis, and biological activity of potent and orally available G protein-coupled receptor 40 agonists. , 2011, Journal of medicinal chemistry.

[17]  L. Aarons,et al.  Critique of the Two-Fold Measure of Prediction Success for Ratios: Application for the Assessment of Drug-Drug Interactions , 2011, Drug Metabolism and Disposition.

[18]  R. Galván,et al.  Glucose-6-phosphate dehydrogenase activity and NADPH/NADP+ ratio in liver and pancreas are dependent on the severity of hyperglycemia in rat. , 2006, Life sciences.

[19]  Thierry Lavé,et al.  An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery. , 2005, Journal of pharmaceutical sciences.

[20]  K. Brouwer,et al.  Viability assessment in sandwich-cultured rat hepatocytes after xenobiotic exposure. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[21]  Richard A Corley,et al.  Metabolic rate constants for hydroquinone in F344 rat and human liver isolated hepatocytes: application to a PBPK model. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  T. M. Lewin,et al.  Rat liver acyl-CoA synthetase 4 is a peripheral-membrane protein located in two distinct subcellular organelles, peroxisomes, and mitochondrial-associated membrane. , 2002, Archives of biochemistry and biophysics.

[23]  V. Anderson,et al.  Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells , 2002, Cancer Chemotherapy and Pharmacology.

[24]  Y. Sugiyama,et al.  Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[25]  M. Iwaki,et al.  Pharmacokinetics of ozagrel and its metabolites after intravenous and oral administrations. , 1997, Journal of pharmaceutical sciences.

[26]  J. Caldwell,et al.  Metabolism of trans-cinnamic acid in the rat and the mouse and its variation with dose. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[27]  H. Schulz,et al.  NADPH-dependent beta-oxidation of unsaturated fatty acids with double bonds extending from odd-numbered carbon atoms. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Baillie,et al.  Studies on the beta-oxidation of valproic acid in rat liver mitochondrial preparations. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[29]  R. Wanders,et al.  Long-chain-acyl-CoA synthetase and very-long-chain-acyl-CoA synthetase activities in peroxisomes and microsomes from rat liver. An enzymological study. , 1991, European journal of biochemistry.

[30]  R. Wanders,et al.  Long‐chain‐acyl‐CoA synthetase activities in peroxisomes and microsomes from rat liver , 1991 .

[31]  G. Labbe,et al.  Tianeptine, a new tricyclic antidepressant metabolized by beta-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice. , 1989, Biochemical pharmacology.

[32]  D. L. Cinti,et al.  Solubilization and purification of hepatic microsomal trans-2-enoyl-CoA reductase: evidence for the existence of a second long-chain enoyl-CoA reductase. , 1985, Archives of biochemistry and biophysics.

[33]  J. Hoskins,et al.  The occurrence, metabolism and toxicity of cinnamic acid and related compounds , 1984, Journal of applied toxicology : JAT.

[34]  T. Watanabe,et al.  Participation of peroxisomal beta-oxidation system in the chain-shortening of a xenobiotic acyl compound. , 1984, Biochemical and biophysical research communications.

[35]  D. L. Cinti,et al.  Biochemical properties of short- and long-chain rat liver microsomal trans-2-enoyl coenzyme A reductase. , 1983, Archives of biochemistry and biophysics.

[36]  J. Bremer.  Carnitine--metabolism and functions. , 1983, Physiological reviews.

[37]  D. L. Cinti,et al.  Kinetic evidence for two separate trans-2-enoyl CoA reductases in rat hepatic microsomes: NADPH-specific short chain- and NAD(P)H-dependent long chain-reductase. , 1983, Biochemical and biophysical research communications.

[38]  D. L. Cinti,et al.  Evidence for a second microsomal trans-2-enoyl coenzyme A reductase in rat liver. NADPH-specific short chain reductase. , 1982, The Journal of biological chemistry.

[39]  G. Mannaerts,et al.  MITOCHONDRIAL AND PEROXISOMAL β‐OXIDATION OF FATTY ACIDS IN RAT LIVER , 1982 .

[40]  P. Lazarow,et al.  Acyl-CoA synthetase in rat liver peroxisomes. Computer-assisted analysis of cell fractionation experiments. , 1980, The Journal of biological chemistry.

[41]  P. Pedersen,et al.  A high-yield preparative method for isolation of rat liver mitochondria. , 1977, Analytical biochemistry.

[42]  A. Wojtczak,et al.  The inhibition of isocitrate oxidation by palmitoyl-l-carnitine and palmitoyl-C0 A in rat liver mitochondria. , 1976, European journal of biochemistry.

[43]  W. Seubert,et al.  On the mechanism of malonyl-CoA-independent fatty-acid synthesis. Different properties of the mitochondrial chain elongation and enoylCoA reductase in various tissues. , 1976, European journal of biochemistry.

[44]  S. Ranganathan,et al.  The metabolism of phenolic acids in the rat. , 1974, The Biochemical journal.

[45]  W. Seubert,et al.  Mechanisms and physiological roles of fatty acid chain elongation in microsomes and mitochondria , 1973, Molecular and Cellular Biochemistry.

[46]  Y. Marcel,et al.  Kinetic studies on the chain length specificity of long chain acyl coenzyme A synthetase from rat liver microsomes. , 1972, The Journal of biological chemistry.

[47]  J. Williamson,et al.  On the mechanism of inhibition of fatty acid oxidation by 4-pentenoic acid in rat liver mitochondria. , 1971, The Journal of biological chemistry.

[48]  Yang Ben-kun.  Studies on the Absolute Bioavailability of Cinnamic Acid in Rats and Its Absorption Properties , 2013 .

[49]  D. Ying.  Determination of(E)-3-(3-methoxy-4-((3,5,6-trimethylpyrazin-2-yl) methoxy)phenyl)acrylate in rat plasma by RP-HPLC , 2012 .

[50]  Wei Ma,et al.  Pharmacokinetics and bioavailability of cinnamic acid after oral administration of ramulus cinnamomi in rats , 2010, European Journal of Drug Metabolism and Pharmacokinetics.

[51]  F. Guengerich.  Cytochrome p450 and chemical toxicology. , 2008, Chemical research in toxicology.

[52]  G. Mannaerts,et al.  Mitochondrial and peroxisomal beta-oxidation of fatty acids in rat liver. , 1982, Annals of the New York Academy of Sciences.